![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 10, 2007 10:37:02 AM
“With the addition of the Genomic Collaborative bio-bank to the company’s comprehensive services, BioServe is on track to become the leader in helping researchers discover and validate a new generation of superior diagnostic and therapeutic targets,” Dr. Krenitsky says. The company currently employs about 55 in Beltsville and its recently opened facility in Hyderabad, India, which is primarily engaged in serving the molecular and genetic diagnostics market in that country. Revenues last year were “just south” of $10 million, Krenitsky notes, and the company is profitable. "
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM